Cynosure Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $409K | Sell |
4,690
-285
| -6% | -$24.9K | 0.05% | 265 |
|
|
2025
Q1 | $340K | Buy |
4,975
+1,288
| +35% | +$88K | 0.05% | 261 |
|
|
2024
Q4 | $287K | Sell |
3,687
-32,545
| -90% | -$2.53M | 0.04% | 306 |
|
|
2024
Q3 | $2.43M | Buy |
36,232
+33,022
| +1,029% | +$2.21M | 0.35% | 42 |
|
|
2024
Q2 | $364K | Buy |
3,210
+873
| +37% | +$99K | 0.06% | 308 |
|
|
2024
Q1 | $324K | Buy |
+2,337
| New | +$324K | 0.06% | 224 |
|